Form 8-K - Current report:
SEC Accession No. 0001437749-25-001922
Filing Date
2025-01-27
Accepted
2025-01-27 17:05:45
Documents
15
Period of Report
2025-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250127_8k.htm   iXBRL 8-K 31450
2 EXHIBIT 4.1 ex_770980.htm EX-4.1 30906
  Complete submission text file 0001437749-25-001922.txt   200496

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20250124.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250124_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250124_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250124_pre.xml EX-101.PRE 11585
17 EXTRACTED XBRL INSTANCE DOCUMENT wint20250127_8k_htm.xml XML 2837
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25559971
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)